EN
HI
Shukra Pharmaceuticals Chart
Shukra Pharmaceuticals Share Key Metrics
Volume
3.36 L
Market Cap
1275.98 CR
LTQ@LTP
500@29.16
ATP
29.19
Var Margin
26.76 %
Circuit Range
27.69-30.59
Delivery %
65.07 %
Value
98.11 L
ASM/GSM
No
Market Lot
1
Summary
Shukra Pharmaceuticals share price is ₹29.16 as of 2 Jun, 2026. The stock Shukra Pharmaceuticals intraday movement has stayed between ₹28.52 and ₹29.89, while on a 52-week basis,Shukra Pharmaceuticals price 52 week high is ₹65.26 & its 52 week low is ₹12.97.
In terms of trading activity, Shukra Pharmaceuticals has recorded a volume of 336104 shares, The Shukra Pharmaceuticals has a market cap of ₹437879440 CR. The stock’s Average Traded Price (ATP) stands at ₹29.19, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 500 @ ₹29.16.
Shukra Pharmaceuticals operates within a circuit range of ₹27.69 – ₹30.59, with a Value of ₹98.11 L. The Delivery Percentage for the day is 65.07%. Additionally, Shukra Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Shukra Pharmaceuticals Fundamentals
View MoreP/E Ratio
58.08
P/B Ratio
0
Div. Yield
0.03
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Shukra Pharmaceuticals Resistance and Support
Pivot 29.37
Resistance
First Resistance
29.74
Second Resistance
30.35
Third Resistance
30.72
Support
First Support
28.76
Second Support
28.39
Third Support
27.78
Shukra Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-03-16 | Others |
| 2026-02-04 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-10-03 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-06-04 | Final Dividend |
| 2025-05-29 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2025-01-29 | Stock Split |
| 2025-01-09 | Others |
Shukra Pharmaceuticals News
Shukra Pharmaceuticals Ltd - 524632 - Corporate Action-Board approves Dividend
Shukra Pharmaceuticals' Board recommended a final dividend of ₹0.01 per equity share for FY26, representing 1% of the share's face value. This payout is contingent on shareholder approval at the upcoming Annual General Meeting.
May 07 2026 22:43:18
Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome For The Board Meeting Dated 07.05.2026 For The Audited Financial Results For The Quarter And Year Ended March, 2026
Shukra Pharmaceuticals reported FY26 cons. revenue of ₹56.73 cr (up 74% YoY) and net profit of ₹22.06 cr (up 130% YoY). The board also recommended a ₹0.01 final dividend and approved conversion of 1.735M promoter warrants.
May 07 2026 22:22:17
Shukra Pharmaceuticals Management
| Name | Position |
|---|---|
| Dakshesh Rameshchandra Shah | Managing Director |
| Payal Mehta | Executive Director |
Shukra Pharmaceuticals Similar Stocks
Syncom Formulations (India) Ltd.
14.94
0.16 (1.08%)
Fredun Pharmaceuticals Ltd.
2375.70
-20.65 (0.86%)
KMC Speciality Hospitals (India) Ltd.
118.90
3.90 (3.39%)
Ind-Swift Laboratories Ltd.
161.15
-2.95 (1.80%)
Laxmi Dental Ltd.
238.65
8.60 (3.74%)
Lincoln Pharmaceuticals Ltd.
590.95
-20.45 (3.34%)
Bajaj Healthcare Ltd.
300.85
6.30 (2.14%)
GPT Healthcare Ltd.
151.30
8.70 (6.10%)
Shukra Pharmaceuticals FAQs
The Buying Price of Shukra Pharmaceuticals share is 29.16 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Shukra Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Shukra Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Shukra Pharmaceuticals shares is 58.08. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Shukra Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Shukra Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Shukra Pharmaceuticals is 1275.98 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Shukra Pharmaceuticals share price is 65.26 & 12.97. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Shukra Pharmaceuticals belongs to the Healthcare sector.
